본문 바로가기
KERD
논문KCI 등재

Glia as a Link between Neuroinflammation and Neuropathic Pain

2

조회

0

다운로드

5

인용

0

참고문헌

키워드

초록

Contemporary studies illustrate that peripheral injuries activate glial components of the peripheral and central cellular circuitry. The subsequent release of glial stressors or activating signals contributes to neuropathic pain and neuroinflammation. Recent studies document the importance of glia in the development and persistence of neuropathic pain and neuroinflammation as a connecting link, thereby focusing attention on the glial pathology as the general underlying factor in essentially all age-related neurodegenerative diseases. There is wide agreement that excessive glial activation is a key process in nervous system disorders involving the release of strong pro-inflammatory cytokines, which can trigger worsening of multiple disease states. This review will briefly discuss the recent findings that have shed light on the molecular and cellular mechanisms of glia as a connecting link between neuropathic pain and neuroinflammation.

Abstract

Contemporary studies illustrate that peripheral injuries activate glial components of the peripheral and central cellular circuitry. The subsequent release of glial stressors or activating signals contributes to neuropathic pain and neuroinflammation. Recent studies document the importance of glia in the development and persistence of neuropathic pain and neuroinflammation as a connecting link, thereby focusing attention on the glial pathology as the general underlying factor in essentially all age-related neurodegenerative diseases. There is wide agreement that excessive glial activation is a key process in nervous system disorders involving the release of strong pro-inflammatory cytokines, which can trigger worsening of multiple disease states. This review will briefly discuss the recent findings that have shed light on the molecular and cellular mechanisms of glia as a connecting link between neuropathic pain and neuroinflammation.

참고문헌 (61)

  1. Kriegstein A, "The glial nature of embryonic and adult neural stem cells", Annu Rev Neurosci, 32, pp.149~184 (2009)
  2. Moalem G, "Immune and inflammatory mechanisms in neuropathic pain", Brain Res Rev, 51, pp.240~264 (2006)
  3. Aamodt S, "Focus on glia and disease", Nat Neurosci, 10, pp.1349~ (2007)
  4. Watkins LR, "Glial activation: a driving force for pathological pain", Trends Neurosci, 24, pp.450~455 (2001)
  5. McMahon SB, "Immune and glial cell factors as pain mediators and modulators", Exp Neurol, 192, pp.444~462 (2005)
  6. Coull JA, "BDNF from microglia causes the shift in neuronal anion gradient underlying neuropathic pain", Nature, 438, pp.1017~1021 (2005)
  7. Garrison CJ, "Staining of glial fibrillary acidic protein (GFAP) in lumbar spinal cord increases following a sciatic nerve constriction injury", Brain Res, 565, pp.1~7 (1991)
  8. Meller ST, "The possible role of glia in nociceptive processing and hyperalgesia in the spinal cord of the rat", Neuropharmacology, 33, pp.1471~1478 (1994)
  9. Colburn RW, "Dissociation of microglial activation and neuropathic pain behaviors following peripheral nerve injury in the rat", J Neuroimmunol, 79, pp.163~175 (1997)
  10. Milligan ED, "Tracey KJ, Maier SF, Watkins LR: Thermal hyperalgesia and mechanical allodynia produced by intrathecal administration of the human immunodeficiency virus-1 (HIV-1) envelope glycoprotein, gp120", Brain Res, 861, pp.105~116 (2000)
  11. Chacur M, "A new model of sciatic inflammatory neuritis (SIN): induction of unilateral and bilateral mechanical allodynia following acute unilateral peri-sciatic immune activation in rats", Pain, 94, pp.231~244 (2001)
  12. Raghavendra V, "Complete Freunds adjuvant- induced peripheral inflammation evokes glial activation and proinflammatory cytokine expression in the CNS", Eur J Neurosci, 20, pp.467~473 (2004)
  13. Möller T, "Neuroinflammation in Huntington's disease", J Neural Transm, 117, pp.1001~1008 (2010)
  14. Björkqvist M, "A novel pathogenic pathway of immune activation detectable before clinical onset in Huntington's disease", J Exp Med, 205, pp.1869~1877 (2008)
  15. Garden GA, "Microglia biology in health and disease", J Neuroimmune Pharmacol, 1, pp.127~137 (2006)
  16. Weydt P, "Neuroinflammation in the pathogenesis of amyotrophic lateral sclerosis", Neuroreport, 16, pp.527~531 (2005)
  17. Block ML, "Microglia and inflammation-mediated neurodegeneration: multiple triggers with a common mechanism", Prog Neurobiol, 76, pp.77~98 (2005)
  18. Mrak RE, "Interleukin-1, neuroinflammation, and Alzheimer's disease", Neurobiol Aging, 22, pp.903~908 (2001)
  19. Phillis JW, "Cyclooxygenases, lipoxygenases, and epoxygenases in CNS: their role and involvement in neurological disorders", Brain Res Rev, 52, pp.201~243 (2006)
  20. Sriram K, "Divergent roles for tumor necrosis factor-alpha in the brain", J Neuroimmune Pharmacol, 2, pp.140~153 (2007)
  21. Ubogu EE, "The expression and function of chemokines involved in CNS inflammation", Trends Pharmacol Sci, 27, pp.48~55 (2006)
  22. Weed DL, "The merger of bioethics and epidemiology", J Clin Epidemiol, 44(1), pp.15S~22S (1991)
  23. Baptista MJ, "Parkin and alpha-synuclein: opponent actions in the pathogenesis of Parkinson's disease", Neuroscientist, 10, pp.63~72 (2004)
  24. Gilron I, "Neuropathic pain: a practical guide for the clinician", CMAJ, 175, pp.265~275 (2006)
  25. Kielian T, "Microglia and chemokines in infectious diseases of the nervous system: views and reviews", Front Biosci, 9, pp.732~750 (2004)
  26. Ransohoff RM, "Chemokines in immune- mediated inflammation of the central nervous system", Cytokine Growth Factor Rev, 7, pp.35~46 (1996)
  27. Cartier L, "Chemokine receptors in the central nervous system: role in brain inflammation and neurodegenerative diseases", Brain Res Brain Res Rev, 48, pp.16~42 (2005)
  28. Kreutzberg GW, "Microglia: a sensor for pathological events in the CNS", Trends Neurosci, 19, pp.312~318 (1996)
  29. Clayton DF, "Synucleins in synaptic plasticity and neurodegenerative disorders", J Neurosci Res, 58, pp.120~129 (1999)
  30. Becher B, "Brain-immune connection: immuno- regulatory properties of CNS-resident cells", Glia, 29, pp.293~304 (2000)
  31. Scholz J, "The neuropathic pain triad: neurons, immune cells and glia", Nat Neurosci, 10, pp.1361~1368 (2007)
  32. Halassa MM, "The tripartite synapse: roles for gliotransmission in health and disease", Trends Mol Med, 13, pp.54~63 (2007)
  33. Pocock JM, "Neurotransmitter receptors on microglia", Trends Neurosci, 30, pp.527~535 (2007)
  34. Watkins LR, "Chapter 22 Contribution of glia to pain processing in health and disease", Handb Clin Neurol, 81, pp.309~323 (2006)
  35. Gwak YS, "Spatial and temporal activation of spinal glial cells: role of gliopathy in central neuropathic pain following spinal cord injury in rats", Exp Neurol, 234, pp.362~372 (2012)
  36. Julius D, "Molecular mechanisms of nociception", Nature, 413, pp.203~210 (2001)
  37. Scholz J, "Can we conquer pain?", Nat Neurosci, 5(Suppl), pp.1062~1067 (2002)
  38. Block ML, "Microglia-mediated neurotoxicity: uncovering the molecular mechanisms", Nat Rev Neurosci, 8, pp.57~69 (2007)
  39. Lobsiger CS, "Glial cells as intrinsic components of non-cell-autonomous neurodegenerative disease", Nat Neurosci, 10, pp.1355~1360 (2007)
  40. Vallejo R, "The role of glia and the immune system in the development and maintenance of neuropathic pain", Pain Pract, 10, pp.167~184 (2010)
  41. Colburn RW, "The effect of site and type of nerve injury on spinal glial activation and neuropathic pain behavior", Exp Neurol, 157, pp.289~304 (1999)
  42. Raghavendra V, "Inhibition of microglial activation attenuates the development but not existing hypersensitivity in a rat model of neuropathy", J Pharmacol Exp Ther, 306, pp.624~630 (2003)
  43. Ledeboer A, "Minocycline attenuates mechanical allodynia and proinflammatory cytokine expression in rat models of pain facilitation", Pain, 115, pp.71~83 (2005)
  44. DeLeo JA, "Physiology of chronic spinal pain syndromes: from animal models to biomechanics", Spine, 27, pp.2526~2537 (2002)
  45. Watkins LR, ""Listening" and "talking" to neurons: implications of immuneactivation for pain control and increasing the efficacy ofopioids", Brain Res Rev, 56, pp.48~69 (2007)
  46. Wieseler-Frank J, "Glial activation and pathological pain", Neurochem Int, 45, pp.389~395 (2004)
  47. Ji RR, "p38 MAPK, microglial signaling, and neuropathic pain", Mol Pain, 3, pp.33~ (2007)
  48. Zhuang ZY, "ERK is sequentially activated in neurons, microglia, and astrocytes by spinal nerve ligation and contributes to mechanical allodynia in this neuropathic pain model", Pain, 114, pp.149~159 (2005)
  49. Dubuisson D, "The formalin test: a quantitative study of the analgesic effects of morphine, meperidine, and brain stem stimulation in rats and cats", Pain, 4, pp.161~174 (1977)
  50. Abbott FV, "The formalin test: scoring properties of the first and second phases of the pain response in rats", Pain, 60, pp.91~102 (1995)
  51. Puig S, "Formalin-evoked activity in identified primary afferent fibers: systemic lidocaine suppresses phase-2 activity", Pain, 64, pp.345~355 (1996)
  52. Tjølsen A, "The formalin test: an evaluation of the method", Pain, 51, pp.5~17 (1992)
  53. Colpaert FC, "Evidence that adjuvant arthritis in the rat is associated with chronic pain", Pain, 28, pp.201~222 (1987)
  54. Millan MJ, "Inflammation of the hind limb as a model of unilateral, localized pain: influence on multiple opioid systems in the spinal cord of the rat", Pain, 35, pp.299~312 (1988)
  55. Iadarola MJ, "Enhancement of dynorphin gene expression in spinal cord following experimental inflammation: stimulus specificity, behavioral parameters and opioid receptor binding", Pain, 35, pp.313~326 (1988)
  56. Lao L, "A parametric study of electroacupuncture on persistent hyperalgesia and Fos protein expression in rats", Brain Res, 1020, pp.18~29 (2004)
  57. Li K, "Peripheral formalin injury induces 2 stages of microglial activation in the spinal cord", J Pain, 11, pp.1056~1065 (2010)
  58. Lin T, "Dissociation of spinal microglia morphological activation and peripheral inflammation in inflammatory pain models", J Neuroimmunol, 192, pp.40~48 (2007)
  59. Ren K, "Neuron-glia crosstalk gets serious: role in pain hypersensitivity", Curr Opin Anaesthesiol, 21, pp.570~579 (2008)
  60. Gao YJ, "Targeting astrocyte signaling for chronic pain", Neurotherapeutics, 7, pp.482~493 (2010)
  61. Watkins LR, "Norman Cousins Lecture. Glia as the "bad guys": implications for improving clinical pain control and the clinical utility of opioids", Brain Behav Immun, 21, pp.131~146 (2007)

관련 논문AI추천

이 간행물의 다른 논문 (3건)